About Maxivision Laboratories Private Limited
Data last updated:
Maxivision Laboratories Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the preventive healthcare segment of the healthcare sector. It was incorporated on 27 January 2016.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2016PTC103853.
The company had an authorised share capital of ₹15.1 Cr and a paid-up capital of ₹15.06 Cr. It was led by directors including Sandip Chandrakant Shah and Rajendran Mohan.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at No 15 4th Street Abhiramapuram, Chennai, Tamil Nadu, India – 600018.
As per the financials filed for FY 2018, the company reported a revenue of ₹9.54 Lakh. For the same year it recorded a net profit of ₹4.72 Lakh (net margin 49.5%) and EBITDA of -₹4.75 Lakh (EBITDA margin -49.8%).
The last known website on record is trivitron.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered AddressNo 15 4th Street Abhiramapuram, Chennai, Tamil Nadu, India – 600018
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Maxivision Laboratories Private Limited FY 2022 filings available
Maxivision Laboratories Private Limited reported revenue of ₹9.54 Lakh for FY 2018.
Financial Statement Summary of Maxivision Laboratories Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | ₹9.54 Lakh | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹4.75 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.72 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Maxivision Laboratories Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -49.8% | •••• | •••• |
| Net Profit Margin | 49.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxivision Laboratories are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maxivision Laboratories Private Limited
Maxivision Laboratories has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandip Chandrakant Shah Also directs: Neuberg Supratech Amreli Laboratory LLP, Diapoint Labs LLP, Neuberg Supratech Jamnagar Laboratory LLP and 5 more | Director | 27 Oct 2017 | 8 Years 11 Months | As last reported |
| Rajendran Mohan | Director | 21 Mar 2022 | 4 Years 7 Months | As last reported |
| Bhavini Sandip Shah | Director | 27 Oct 2017 | 8 Years 11 Months | As last reported |
Auditor Details of Maxivision Laboratories Private Limited
Maxivision Laboratories Private Limited is audited by R SUBRAMANIAN AND COMPANY LLP for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R SUBRAMANIAN AND COMPANY LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maxivision Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxivision Laboratories Private Limited
Maxivision Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxivision Laboratories Private Limited
Employment history and EPFO contributions of people linked to Maxivision Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxivision Laboratories Private Limited
Maxivision Laboratories Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Nikita Shah Pratik ceased to be Company Secretary on 30 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Maxivision Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxivision Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxivision Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxivision Laboratories Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxivision Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxivision Laboratories Private Limited
Maxivision Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Maxivision Laboratories was a private limited company based in Chennai, Tamil Nadu, India. The company worked in preventive health services, within the healthcare industry. It was incorporated on 27 January 2016 and is registered under CIN U74900TN2016PTC103853. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Maxivision Laboratories was incorporated on 27 January 2016. It is registered with the Registrar of Companies, Chennai.
Maxivision Laboratories had 3 directors:
- Sandip Chandrakant Shah - Director
- Rajendran Mohan - Director
- Bhavini Sandip Shah - Director
The CIN (Corporate Identification Number) of Maxivision Laboratories is U74900TN2016PTC103853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Maxivision Laboratories is at No 15 4th Street Abhiramapuram, Chennai, Tamil Nadu, India – 600018.
Maxivision Laboratories can be reached through the website trivitron.com. Its registered office is in Chennai, Tamil Nadu, India.
Maxivision Laboratories reported revenue of ₹9.54 Lakh for FY 2018.
Maxivision Laboratories has an authorised share capital of ₹15.1 Cr and a paid-up capital of ₹15.06 Cr.
Maxivision Laboratories reported a net profit of ₹4.72 Lakh (net margin 49.5%) and EBITDA of -₹4.75 Lakh (EBITDA margin -49.8%) for FY 2018, as per its filed financial statements.